Survivin-T34A: molecular mechanism and therapeutic potential. - Wikidata - wikimedia - TriplyDB

Survivin-T34A: molecular mechanism and therapeutic potential.

Survivin-T34A: molecular mechanism and therapeutic potential.

http://www.wikidata.org/entity/Q37834973

about

Mechanisms of the anti-tumor activity of Methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo[d]imidazole-5-carboxylate against breast cancer in vitro and in vivo Cellular inhibitor of apoptosis protein 1 (cIAP1) stability contributes to YM155 resistance in human gastric cancer cells.A novel antagonist to the inhibitors of apoptosis (IAPs) potentiates cell death in EGFR-overexpressing non-small-cell lung cancer cells Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene.Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant.Clinico-pathologic relevance of Survivin splice variant expression in cancer Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells.Elucidating respective functions of two domains BIR and C-helix of human IAP survivin for precise targeted regulating mitotic cycle, apoptosis and autophagy of cancer cells.Survivin-Based Treatment Strategies for Squamous Cell Carcinoma.Targeting PRPK Function Blocks Colon Cancer Metastasis.Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle

P2860

Q33709918-97F1EF55-52CD-4180-BED8-DA3C9E451DD8 Q34460429-FBD8D4C7-840C-4DB2-B6E0-B8B77DDB1055 Q35338435-F68EA0E6-F021-463E-B736-94ED87DDC164 Q36557697-ACAEDE02-9D42-4EF9-8274-C304E1B7864B Q37593002-74857718-B711-4752-B854-B006B921D747 Q38116267-106C10BC-E770-4031-AEBE-65F9126446F5 Q39105855-9A7B55CC-CCB5-42E6-9FC9-6167C5D86346 Q49200938-ABBFAF4B-0F4C-4659-9FF7-A2F1D6944D9A Q51758973-684A911D-98AA-4533-BD00-73942443826D Q52684446-740D69DA-0AE8-4D83-AAF9-D0A2FE522CC4 Q58746877-F99E50FC-90AF-45B9-91EF-5F7433CAF46C

P2860

Survivin-T34A: molecular mechanism and therapeutic potential.

http://www.wikidata.org/entity/Q37834973

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Survivin-T34A: molecular mechanism and therapeutic potential.

@en

Survivin-T34A: molecular mechanism and therapeutic potential.

@nl

type

label

Survivin-T34A: molecular mechanism and therapeutic potential.

@en

Survivin-T34A: molecular mechanism and therapeutic potential.

@nl

prefLabel

Survivin-T34A: molecular mechanism and therapeutic potential.

@en

Survivin-T34A: molecular mechanism and therapeutic potential.

@nl

P1433

Q37834973-C43CBB27-CD06-4FEC-82CD-825B48540586

P1476

Q37834973-ADBC3114-ED21-4860-80AD-948097A6ADD6

P2093

Q37834973-65FBF9A3-652A-46EE-90EE-48330A948472

P2860

Q37834973-01F9899C-FDF1-4EF4-8F15-97698434B59B

Q37834973-025847F3-397D-42CD-8C4A-06743136DEA6

Q37834973-062F8F66-4A99-4885-B417-3B5E31421E26

Q37834973-0EA3D635-4B1E-4F85-ACD1-09007AC49AA9

Q37834973-0ECF46E0-E2F8-4E64-A0F7-4D655C7E29F8

Q37834973-0F02DF2A-2E1D-4A96-B327-26557BCC5AA4

Q37834973-1106E9D0-EC9C-45C8-857C-8B18356A0B40

Q37834973-23B2B5C4-7481-4CAD-B904-72412192DDA0

Q37834973-25940F0A-ACC4-4BF8-ADB9-71CA7C67179F

Q37834973-27DC86AB-CE94-45EF-9326-FBB90ADA0244

P304

Q37834973-9C3B27D3-BFE3-4739-8D52-A1445FFB72D0

P31

Q37834973-71B2D341-078D-4007-AEF3-2C3784AA2B42

P356

Q37834973-BC1F9D6B-ADB9-4AD9-81DA-0CED661B7277

P407

Q37834973-0069744F-9350-4475-A2ED-6970057373D6

P478

Q37834973-DD605073-65CD-42D7-9E5E-37C73A5F07A6

P50

Q37834973-6253484A-5637-425D-B61A-EE2C0516E89E

P577

Q37834973-13DBC280-8812-4078-8B91-D232A607CDFE

P5875

Q37834973-E6801141-C9F7-4B79-A542-D2EB4F07A1C6

P698

Q37834973-51D0FE04-4665-4147-9A85-5A0D6F91E20C

P932

Q37834973-33C417B7-1888-4047-B064-D2474E0DDD27

P356

P1433

OncoTargets and Therapy

P1476

Survivin-T34A: molecular mechanism and therapeutic potential

@en

P2093

Jonathan R Aspe

http://www.w3.org/2001/XMLSchema#string

P2860

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

Control of apoptosis and mitotic spindle checkpoint by survivin

The Hallmarks of Cancer

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7

A p34(cdc2) survival checkpoint in cancer

Survivin mediates resistance to antiandrogen therapy in prostate cancer

IAP family proteins--suppressors of apoptosis

The Survivin saga goes in vivo

P304

247-254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S15293

http://www.w3.org/2001/XMLSchema#string

P407

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49806463

http://www.w3.org/2001/XMLSchema#string

P698

21289859

http://www.w3.org/2001/XMLSchema#string

P932

3024888

http://www.w3.org/2001/XMLSchema#string